cancer_group,alteration_group,confounder,ras,nonras,cancer,number_ras,number_nonras,Parameter,mean,se_mean,sd,2.5%,5%,25%,50%,75%,95%,97.5%,n_eff,Rhat,variable,z,p,00,10,01,11,n,chisq_stat,chisq_p,chisq_padj,is_driver,cutoff_nmodel,cutoff_ntest
single,Rearrangement,sample_type,RAS_12-61,FGFR3,bladder cancer,107,11,"beta[1,4]",-4.887,0.111,3.842,-14.254,-12.033,-6.658,-3.994,-2.24,-0.291,0.178,1203.46,1.007,Primary,-1.272,0.69,1046,107,11,0,1164,0.287,0.23,0.08,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,FGFR3,cns cancer,50,28,"beta[1,4]",-4.422,0.133,4.583,-15.332,-12.284,-6.376,-3.516,-1.453,0.461,0.942,1192.707,1.003,Primary,-0.965,0.48,3444,50,28,0,3522,0,0,0,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,RET,non-small cell lung cancer,1008,29,"beta[1,4]",-6.293,0.092,2.58,-12.704,-11.178,-7.682,-5.879,-4.433,-2.966,-2.581,779.393,1,Metastasis,-2.44,1.83,2716,1008,29,0,3753,9.398,2.66,1.98,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,RET,non-small cell lung cancer,1930,31,"beta[2,4]",-6.315,0.097,2.583,-12.602,-11.196,-7.741,-5.911,-4.445,-2.967,-2.575,710.564,1,Primary,-2.445,1.84,4098,1930,31,0,6059,13.127,3.54,2.76,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,RET,thyroid cancer,63,14,"beta[1,4]",-5.751,0.152,4.503,-15.187,-12.773,-7.765,-4.731,-2.871,-1.057,-0.629,880.704,1.007,Metastasis,-1.277,0.7,326,63,14,0,403,1.6,0.69,0.31,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,TMPRSS2,prostate cancer,11,190,"beta[1,4]",-1.087,0.073,0.679,-2.538,-2.255,-1.522,-1.053,-0.557,-0.181,-0.032,87.148,1.054,Metastasis,-1.6,0.96,548,10,189,1,748,0.815,0.44,0.2,FALSE,2.26,2.86
single,Rearrangement,sample_type,RAS_12-61,TMPRSS2,prostate cancer,18,276,"beta[3,4]",-1.053,0.071,0.648,-2.4,-2.147,-1.487,-1.053,-0.541,-0.173,-0.046,82.9,1.054,Primary,-1.625,0.98,976,16,274,2,1268,0.665,0.38,0.18,FALSE,2.26,2.86
single,Rearrangement,sample_type,RAS_12-61,EGFR,cns cancer,50,189,"beta[1,4]",-5.695,0.115,4.243,-15.262,-12.724,-7.456,-4.752,-2.913,-1.095,-0.747,1353.098,1.002,Primary,-1.342,0.75,3290,50,189,0,3529,1.898,0.77,0.35,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,NF1,breast cancer,39,15,"beta[1,4]",-3.941,0.159,5.318,-15.342,-12.342,-6.241,-2.906,-0.408,1.724,2.251,1119.251,0.999,Primary,-0.741,0.34,5500,39,15,0,5554,0,0,0,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,FGFR2,hepatobiliary cancer,62,14,"beta[1,4]",-5.896,0.223,2.696,-11.951,-10.711,-7.62,-5.302,-3.931,-2.254,-1.867,146.338,1.011,Metastasis,-2.187,1.54,363,62,14,0,439,1.327,0.6,0.26,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,FGFR2,hepatobiliary cancer,103,44,"beta[2,4]",-5.907,0.216,2.655,-11.652,-10.642,-7.505,-5.303,-3.965,-2.3,-1.96,150.728,1.011,Primary,-2.225,1.58,750,103,44,0,897,4.873,1.56,1.09,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,ERG,prostate cancer,11,161,"beta[1,4]",-1.453,0.026,0.843,-3.274,-2.931,-2.017,-1.394,-0.838,-0.183,0.031,1048.938,0.999,Metastasis,-1.723,1.07,581,10,160,1,752,0.401,0.28,0.1,FALSE,2.26,2.86
single,Rearrangement,sample_type,RAS_12-61,ERG,prostate cancer,18,225,"beta[3,4]",-1.509,0.025,0.841,-3.368,-3.02,-2.023,-1.452,-0.884,-0.267,-0.108,1173.251,1,Primary,-1.794,1.14,1025,17,224,1,1267,1.111,0.53,0.23,FALSE,2.26,2.86
single,Rearrangement,sample_type,RAS_12-61,ROS1,non-small cell lung cancer,801,27,"beta[1,4]",-3.564,0.052,1.236,-6.666,-5.956,-4.218,-3.376,-2.708,-1.878,-1.726,561.806,1.002,Metastasis,-2.883,2.4,2178,800,26,1,3005,6.204,1.89,1.36,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,ROS1,non-small cell lung cancer,1449,36,"beta[2,4]",-3.842,0.054,1.316,-7.149,-6.415,-4.531,-3.6,-2.962,-2.132,-1.897,590.029,1.001,Primary,-2.918,2.45,3134,1449,36,0,4619,15.149,4,3.1,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,BRAF,cns cancer,6,38,"beta[1,4]",-4.752,0.096,3.708,-12.703,-11.498,-6.862,-4.075,-2.09,0.063,0.609,1479.672,1.001,Not Applicable or Heme,-1.281,0.7,482,6,38,0,526,0,0,0,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,BRAF,cns cancer,50,21,"beta[2,4]",-4.661,0.099,3.624,-13.025,-11.484,-6.771,-4.109,-1.937,0.193,0.747,1347.201,1.001,Primary,-1.286,0.7,3451,50,21,0,3522,0,0,0,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,BRAF,melanoma,468,22,"beta[1,4]",-6.392,0.192,4.414,-16.397,-13.588,-8.153,-5.392,-3.561,-2.23,-1.868,527.619,1.003,Metastasis,-1.448,0.83,1248,468,22,0,1738,6.883,2.06,1.46,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,BRAF,prostate cancer,11,11,"beta[1,4]",-3.848,0.128,4.454,-14.137,-11.914,-6.288,-3.035,-0.542,1.631,2.114,1210.999,0.999,Metastasis,-0.864,0.41,880,11,11,0,902,0,0,0,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,ETV6,breast cancer,22,15,"beta[1,4]",-3.723,0.169,4.974,-14.264,-11.723,-5.906,-2.738,-0.343,1.813,2.25,867.115,1.001,Primary,-0.748,0.34,3045,22,15,0,3082,0,0,0,FALSE,2.26,2.86
single,Rearrangement,sample_type,RAS_12-61,ETV6,head and neck cancer,17,11,"beta[1,4]",-4.54,0.178,4.75,-15.847,-12.999,-6.569,-3.58,-1.282,0.637,1.123,715.502,1.004,Metastasis,-0.956,0.47,489,17,11,0,517,0,0,0,FALSE,2.26,2.86
single,Rearrangement,sample_type,RAS_12-61,ALK,non-small cell lung cancer,1008,69,"beta[1,4]",-7.143,0.082,2.678,-13.373,-12.451,-8.713,-6.565,-5.15,-3.756,-3.25,1070.326,1.005,Metastasis,-2.667,2.12,2671,1008,69,0,3748,24.485,6.13,4.75,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,ALK,non-small cell lung cancer,1906,46,"beta[2,4]",-7.072,0.079,2.656,-13.45,-12.082,-8.733,-6.616,-5.079,-3.552,-3.147,1120.558,1.004,Primary,-2.662,2.11,4016,1906,46,0,5968,20.297,5.18,4.1,TRUE,3.21,3.81
single,Rearrangement,sample_type,RAS_12-61,CDKN2A,non-small cell lung cancer,1767,15,"beta[1,4]",0.585,0.015,0.512,-0.413,-0.271,0.246,0.583,0.902,1.457,1.627,1225.021,1.001,Primary,1.143,0.6,3745,1760,8,7,5520,0.886,0.46,0.2,TRUE,3.21,3.81
single,Rearrangement,sample_type,KRAS_12-61,FGFR3,bladder cancer,60,11,"beta[1,4]",-4.846,0.131,4.535,-14.667,-12.69,-6.75,-3.981,-1.889,0.173,0.595,1201.35,1,Primary,-1.069,0.54,1093,60,11,0,1164,0.008,0.03,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,FGFR3,cns cancer,29,28,"beta[1,4]",-4.423,0.152,4.942,-16.229,-12.645,-6.588,-3.539,-1.131,1.067,1.543,1058.675,1.002,Primary,-0.895,0.43,3465,29,28,0,3522,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,RET,non-small cell lung cancer,971,29,"beta[1,4]",-6.32,0.089,2.61,-12.323,-11.188,-7.798,-5.828,-4.432,-2.872,-2.624,853.57,1.006,Metastasis,-2.421,1.81,2753,971,29,0,3753,8.886,2.54,1.96,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,RET,non-small cell lung cancer,1880,31,"beta[2,4]",-6.348,0.087,2.616,-12.449,-11.294,-7.754,-5.854,-4.477,-3.038,-2.642,898.962,1.004,Primary,-2.427,1.82,4148,1880,31,0,6059,12.598,3.41,2.74,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,RET,thyroid cancer,10,14,"beta[1,4]",-4.421,0.262,4.796,-15.236,-12.485,-6.477,-3.615,-1.062,0.994,1.692,334.639,1.014,Metastasis,-0.922,0.45,379,10,14,0,403,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,TMPRSS2,prostate cancer,7,276,"beta[3,4]",-1.349,0.036,1.106,-3.883,-3.29,-1.974,-1.253,-0.612,0.262,0.533,919.065,1.001,Primary,-1.22,0.65,986,6,275,1,1268,0,0.01,0,FALSE,2.26,2.26
single,Rearrangement,sample_type,KRAS_12-61,EGFR,cns cancer,29,189,"beta[1,4]",-5.534,0.186,4.261,-14.563,-12.768,-7.34,-4.424,-2.856,-0.876,-0.449,523.77,1.004,Primary,-1.299,0.71,3311,29,189,0,3529,0.761,0.42,0.14,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,NF1,breast cancer,27,15,"beta[1,4]",-3.897,0.138,4.987,-15.07,-12.24,-6.484,-3.271,-0.359,2.042,2.545,1307.97,1.003,Primary,-0.781,0.36,5512,27,15,0,5554,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,FGFR2,hepatobiliary cancer,53,14,"beta[1,4]",-6.143,0.72,3.607,-16.004,-15.201,-7.791,-5.317,-3.548,-1.818,-1.376,25.057,1.124,Metastasis,-1.703,1.05,372,53,14,0,439,0.985,0.49,0.17,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,FGFR2,hepatobiliary cancer,82,44,"beta[2,4]",-6.178,0.731,3.596,-15.931,-15.102,-7.76,-5.367,-3.555,-1.964,-1.531,24.225,1.12,Primary,-1.718,1.07,771,82,44,0,897,3.57,1.23,0.8,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,ERG,prostate cancer,7,225,"beta[3,4]",-1.156,0.048,1.134,-3.876,-3.33,-1.731,-0.946,-0.47,0.4,0.624,553.142,1.017,Primary,-1.019,0.51,1036,6,224,1,1267,0,0,0,FALSE,2.26,2.26
single,Rearrangement,sample_type,KRAS_12-61,ROS1,non-small cell lung cancer,768,27,"beta[1,4]",-3.42,0.035,1.154,-6.01,-5.498,-4.088,-3.279,-2.628,-1.776,-1.556,1094.804,1,Metastasis,-2.965,2.52,2211,767,26,1,3005,5.729,1.78,1.28,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,ROS1,non-small cell lung cancer,1412,36,"beta[2,4]",-3.733,0.036,1.262,-6.51,-5.848,-4.364,-3.546,-2.89,-2.033,-1.787,1230.493,1.001,Primary,-2.957,2.51,3171,1412,36,0,4619,14.556,3.87,3.06,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,BRAF,cns cancer,29,21,"beta[2,4]",-4.094,0.096,3.643,-12.38,-11.02,-6.19,-3.612,-1.339,0.828,1.51,1445.188,1,Primary,-1.124,0.58,3472,29,21,0,3522,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,BRAF,melanoma,21,22,"beta[1,4]",-4.464,0.157,4.791,-15.681,-13.079,-6.765,-3.358,-1.228,0.983,1.366,930.697,1.001,Metastasis,-0.932,0.45,1695,21,22,0,1738,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,ETV6,breast cancer,15,15,"beta[1,4]",-3.686,0.142,4.896,-14.472,-11.88,-6.098,-2.875,-0.219,2.126,2.595,1181.167,1.001,Primary,-0.753,0.35,3052,15,15,0,3082,0,0,0,FALSE,2.26,2.26
single,Rearrangement,sample_type,KRAS_12-61,ALK,non-small cell lung cancer,971,69,"beta[1,4]",-6.957,0.071,2.604,-13.412,-12.081,-8.387,-6.472,-5.037,-3.605,-3.223,1359.844,0.998,Metastasis,-2.672,2.12,2708,971,69,0,3748,23.223,5.84,4.56,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,ALK,non-small cell lung cancer,1858,46,"beta[2,4]",-6.891,0.072,2.627,-13.48,-12.145,-8.322,-6.416,-4.984,-3.617,-3.244,1343.649,0.999,Primary,-2.623,2.06,4064,1858,46,0,5968,19.519,5,4.02,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12-61,CDKN2A,non-small cell lung cancer,1723,15,"beta[1,4]",0.626,0.014,0.525,-0.437,-0.254,0.275,0.639,0.976,1.473,1.634,1392.156,0.998,Primary,1.192,0.63,3789,1716,8,7,5520,1.029,0.51,0.17,TRUE,3.21,3.71
single,Rearrangement,sample_type,HRAS_12-61,FGFR3,bladder cancer,44,11,"beta[1,4]",-4.679,0.13,4.324,-14.508,-12.149,-6.753,-3.923,-1.56,0.484,1.001,1098.15,1.001,Primary,-1.082,0.55,1109,44,11,0,1164,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,HRAS_12-61,RET,non-small cell lung cancer,11,29,"beta[1,4]",-2.794,0.621,3.598,-10.935,-9.318,-5.076,-2.262,0.329,1.782,2.187,33.53,1.086,Metastasis,-0.776,0.36,3713,11,29,0,3753,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,HRAS_12-61,RET,non-small cell lung cancer,7,31,"beta[2,4]",-2.809,0.611,3.664,-10.815,-9.557,-5.098,-2.263,0.325,1.847,2.214,35.92,1.078,Primary,-0.767,0.35,6021,7,31,0,6059,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,HRAS_12-61,RET,thyroid cancer,10,14,"beta[1,4]",-4.411,0.108,4.109,-13.854,-11.401,-6.423,-3.63,-1.474,0.492,0.98,1448.219,1,Metastasis,-1.073,0.55,379,10,14,0,403,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,HRAS_12-61,TMPRSS2,prostate cancer,7,190,"beta[1,4]",-2.068,0.044,1.212,-4.768,-4.242,-2.754,-1.996,-1.227,-0.281,-0.032,761.941,1.002,Metastasis,-1.706,1.06,551,7,190,0,748,1.243,0.58,0,FALSE,2.26,2.86
single,Rearrangement,sample_type,HRAS_12-61,TMPRSS2,prostate cancer,8,276,"beta[3,4]",-1.899,0.046,1.164,-4.41,-3.953,-2.606,-1.84,-1.086,-0.121,0.112,633.844,1.002,Primary,-1.631,0.99,985,7,275,1,1268,0.043,0.08,0,FALSE,2.26,2.86
single,Rearrangement,sample_type,HRAS_12-61,NF1,breast cancer,11,15,"beta[1,4]",-3.39,0.186,5.854,-16.082,-12.348,-5.874,-2.31,0.443,2.969,3.663,986.651,1.002,Primary,-0.579,0.25,5527,11,15,0,5553,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,HRAS_12-61,ERG,prostate cancer,7,161,"beta[1,4]",-5.43,0.142,3.029,-12.393,-10.86,-7.457,-4.955,-3.161,-1.283,-0.765,453.852,1.003,Metastasis,-1.793,1.14,584,7,161,0,752,0.855,0.45,0,FALSE,2.26,2.86
single,Rearrangement,sample_type,HRAS_12-61,ERG,prostate cancer,8,225,"beta[3,4]",-5.412,0.143,3.026,-12.389,-10.975,-7.393,-5.015,-3.095,-1.274,-0.866,444.87,1.004,Primary,-1.788,1.13,1034,8,225,0,1267,0.73,0.41,0,FALSE,2.26,2.86
single,Rearrangement,sample_type,HRAS_12-61,ROS1,non-small cell lung cancer,10,27,"beta[1,4]",-2.516,0.353,3.593,-10.866,-9.363,-4.735,-1.895,0.366,2.017,2.281,103.708,1.026,Metastasis,-0.7,0.32,2968,10,27,0,3005,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,HRAS_12-61,BRAF,melanoma,25,22,"beta[1,4]",-4.844,0.369,9.137,-15.321,-12.541,-6.664,-3.638,-1.246,0.67,1.064,612.925,1.007,Metastasis,-0.53,0.22,1691,25,22,0,1738,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,HRAS_12-61,BRAF,prostate cancer,7,11,"beta[1,4]",-3.511,0.136,4.592,-13.361,-11.122,-5.795,-2.559,-0.272,1.916,2.44,1137.089,0.999,Metastasis,-0.765,0.35,884,7,11,0,902,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,HRAS_12-61,ETV6,breast cancer,7,15,"beta[1,4]",-3.533,0.187,5.392,-14.624,-12.288,-6.298,-2.482,0.064,2.695,3.171,833.4,1.001,Primary,-0.655,0.29,3060,7,15,0,3082,0,0,0,FALSE,2.26,2.86
single,Rearrangement,sample_type,HRAS_12-61,ETV6,head and neck cancer,10,11,"beta[1,4]",-4.218,0.127,4.441,-13.995,-12.074,-6.508,-3.282,-1.008,0.97,1.399,1219.458,1.001,Metastasis,-0.95,0.47,496,10,11,0,517,0,0,0,FALSE,2.26,2.86
single,Rearrangement,sample_type,HRAS_12-61,ALK,non-small cell lung cancer,11,69,"beta[1,4]",-3.4,0.163,3.361,-10.359,-9.21,-5.607,-3.065,-0.851,1.277,1.612,423.535,1.005,Metastasis,-1.011,0.51,3668,11,69,0,3748,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,HRAS_12-61,ALK,non-small cell lung cancer,6,46,"beta[2,4]",-3.279,0.177,3.421,-10.904,-9.37,-5.485,-2.94,-0.686,1.593,2.034,374.113,1.005,Primary,-0.959,0.47,5916,6,46,0,5968,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,HRAS_12-61,CDKN2A,non-small cell lung cancer,6,15,"beta[1,4]",-3.069,0.155,5.134,-15.006,-11.749,-5.863,-2.131,0.511,3.133,3.713,1090.976,0.999,Primary,-0.598,0.26,5499,6,15,0,5520,0,0,0,TRUE,2.99,3.38
single,Rearrangement,sample_type,NRAS_12-61,FGFR3,bladder cancer,8,11,"beta[1,4]",-3.618,0.136,5.15,-14.774,-11.563,-5.871,-2.568,-0.434,2.051,2.538,1443.393,1.001,Primary,-0.703,0.32,1145,8,11,0,1164,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,FGFR3,cns cancer,18,28,"beta[1,4]",-4.072,0.152,4.88,-14.595,-11.902,-6.392,-3.225,-0.807,1.65,2.071,1029.717,1.001,Primary,-0.834,0.39,3476,18,28,0,3522,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,RET,non-small cell lung cancer,26,29,"beta[1,4]",-4.24,0.452,3.546,-12.335,-11.921,-6.127,-3.499,-1.585,0.326,0.851,61.442,1.051,Metastasis,-1.196,0.63,3698,26,29,0,3753,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,RET,non-small cell lung cancer,50,31,"beta[2,4]",-4.229,0.46,3.563,-12.31,-11.891,-6.122,-3.513,-1.609,0.346,0.835,59.916,1.057,Primary,-1.187,0.63,5978,50,31,0,6059,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,RET,thyroid cancer,43,14,"beta[1,4]",-5.279,0.107,4.023,-15.359,-12.749,-7.068,-4.401,-2.498,-0.774,-0.407,1405.97,1.004,Metastasis,-1.312,0.72,346,43,14,0,403,0.767,0.42,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,EGFR,cns cancer,18,189,"beta[1,4]",-5.151,0.109,4.05,-15.031,-12.44,-7.16,-4.45,-2.313,-0.278,0.131,1374.791,0.999,Primary,-1.272,0.69,3322,18,189,0,3529,0.237,0.2,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,FGFR2,hepatobiliary cancer,9,14,"beta[1,4]",-4.348,0.145,3.199,-11.217,-10.261,-6.431,-3.703,-1.915,-0.156,0.154,489.54,1.003,Metastasis,-1.359,0.76,416,9,14,0,439,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,FGFR2,hepatobiliary cancer,20,44,"beta[2,4]",-4.402,0.147,3.175,-11.291,-10.295,-6.417,-3.757,-1.889,-0.266,0.049,468.448,1.003,Primary,-1.387,0.78,833,20,44,0,897,0.254,0.21,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,ROS1,non-small cell lung cancer,23,27,"beta[1,4]",-3.564,0.149,2.947,-9.961,-8.976,-5.14,-2.972,-1.538,0.255,0.753,390.944,1.005,Metastasis,-1.209,0.64,2955,23,27,0,3005,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,ROS1,non-small cell lung cancer,37,36,"beta[2,4]",-3.53,0.154,2.875,-10.212,-9.037,-5.172,-2.91,-1.486,0.256,0.627,349.677,1.005,Primary,-1.228,0.66,4546,37,36,0,4619,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,BRAF,cns cancer,18,21,"beta[2,4]",-3.926,0.092,3.652,-11.757,-10.468,-6.076,-3.417,-1.265,1.246,1.738,1589.538,1.001,Primary,-1.075,0.55,3483,18,21,0,3522,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,BRAF,melanoma,422,22,"beta[1,4]",-6.511,0.15,5.168,-16.074,-13.491,-8.303,-5.545,-3.728,-1.97,-1.613,1183.367,0.998,Metastasis,-1.26,0.68,1294,422,22,0,1738,5.87,1.81,0.64,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,ALK,non-small cell lung cancer,26,69,"beta[1,4]",-4.3,0.101,3.255,-11.793,-10.147,-6.379,-3.686,-1.772,-0.008,0.419,1045.377,1.001,Metastasis,-1.321,0.73,3653,26,69,0,3748,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,ALK,non-small cell lung cancer,49,46,"beta[2,4]",-4.302,0.098,3.264,-11.749,-10.12,-6.389,-3.765,-1.829,0.131,0.564,1098.043,1.001,Primary,-1.318,0.73,5873,49,46,0,5968,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,NRAS_12-61,CDKN2A,non-small cell lung cancer,43,15,"beta[1,4]",-3.802,0.124,4.467,-14.49,-11.725,-6.024,-3.048,-0.515,1.638,2.195,1287.446,1.004,Primary,-0.851,0.4,5462,43,15,0,5520,0,0,0,TRUE,3.11,3.65
single,Rearrangement,sample_type,RAS_12,FGFR3,bladder cancer,64,11,"beta[1,4]",-4.817,0.128,4.559,-15.315,-12.441,-6.841,-3.914,-1.713,0.289,0.818,1262.362,1,Primary,-1.057,0.54,1089,64,11,0,1164,0.019,0.05,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,FGFR3,cns cancer,23,28,"beta[1,4]",-4.229,0.159,4.537,-14.686,-11.797,-6.481,-3.391,-1.04,1.16,1.679,810.402,0.998,Primary,-0.932,0.45,3471,23,28,0,3522,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,RET,non-small cell lung cancer,820,29,"beta[1,4]",-6.34,0.091,2.658,-12.969,-11.642,-7.782,-5.825,-4.456,-2.861,-2.5,858.771,0.999,Metastasis,-2.385,1.77,2904,820,29,0,3753,6.932,2.07,1.47,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,RET,non-small cell lung cancer,1673,31,"beta[2,4]",-6.341,0.084,2.654,-12.818,-11.647,-7.733,-5.815,-4.452,-2.97,-2.527,998.556,1,Primary,-2.389,1.77,4355,1673,31,0,6059,10.537,2.93,2.23,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,RET,thyroid cancer,7,14,"beta[1,4]",-4.022,0.221,4.84,-13.93,-11.526,-5.929,-3.137,-0.889,0.949,1.483,477.993,1.013,Metastasis,-0.831,0.39,382,7,14,0,403,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,TMPRSS2,prostate cancer,6,276,"beta[3,4]",-1.012,0.033,1.173,-3.735,-3.087,-1.64,-0.894,-0.202,0.68,0.932,1246.237,0.999,Primary,-0.863,0.41,987,5,275,1,1268,0,0,0,FALSE,2.26,2.51
single,Rearrangement,sample_type,RAS_12,EGFR,cns cancer,23,189,"beta[1,4]",-5.097,0.132,3.939,-14.596,-12.306,-6.899,-4.296,-2.245,-0.488,-0.063,884.684,1.004,Primary,-1.294,0.71,3317,23,189,0,3529,0.462,0.3,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,NF1,breast cancer,33,15,"beta[1,4]",-4.01,0.151,4.882,-15.085,-12.954,-6.415,-3.094,-0.535,1.822,2.244,1050.227,1.003,Primary,-0.821,0.39,5506,33,15,0,5554,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,FGFR2,hepatobiliary cancer,45,14,"beta[1,4]",-5.46,0.098,2.907,-12.859,-10.987,-7.078,-4.969,-3.306,-1.694,-1.306,877.976,1.001,Metastasis,-1.878,1.22,380,45,14,0,439,0.701,0.4,0.01,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,FGFR2,hepatobiliary cancer,72,44,"beta[2,4]",-5.491,0.103,2.898,-12.639,-10.845,-7.037,-4.966,-3.331,-1.778,-1.256,788.512,1.001,Primary,-1.895,1.24,781,72,44,0,897,2.976,1.07,0.62,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,ERG,prostate cancer,6,225,"beta[3,4]",-0.588,0.124,1.235,-3.409,-2.738,-1.389,-0.38,0.433,1.063,1.254,99.655,1.031,Primary,-0.476,0.2,1037,5,224,1,1267,0,0,0,FALSE,2.26,2.51
single,Rearrangement,sample_type,RAS_12,ROS1,non-small cell lung cancer,657,27,"beta[1,4]",-3.15,0.034,1.154,-5.78,-5.297,-3.823,-2.996,-2.331,-1.534,-1.325,1164.249,1.002,Metastasis,-2.729,2.2,2322,656,26,1,3005,4.241,1.4,0.88,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,ROS1,non-small cell lung cancer,1264,36,"beta[2,4]",-3.504,0.036,1.253,-6.527,-5.766,-4.161,-3.311,-2.612,-1.901,-1.748,1201.166,1.003,Primary,-2.798,2.29,3319,1264,36,0,4619,12.317,3.35,2.52,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,BRAF,cns cancer,23,21,"beta[2,4]",-4.009,0.094,3.747,-12.504,-10.804,-6.282,-3.512,-1.236,1.112,1.621,1598.285,1.001,Primary,-1.07,0.55,3478,23,21,0,3522,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,BRAF,melanoma,40,22,"beta[1,4]",-4.428,0.117,4.064,-14.067,-11.88,-6.417,-3.754,-1.471,0.487,0.878,1200.599,0.999,Metastasis,-1.089,0.56,1676,40,22,0,1738,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,ETV6,breast cancer,19,15,"beta[1,4]",-3.539,0.118,4.264,-13.337,-11.067,-5.741,-2.948,-0.554,1.892,2.234,1311.69,1,Primary,-0.83,0.39,3048,19,15,0,3082,0,0,0,FALSE,2.26,2.51
single,Rearrangement,sample_type,RAS_12,ETV6,head and neck cancer,9,11,"beta[1,4]",-4.174,0.159,4.287,-13.598,-11.829,-6.044,-3.84,-1.052,1.293,1.741,730.647,1.002,Metastasis,-0.974,0.48,497,9,11,0,517,0,0,0,FALSE,2.26,2.51
single,Rearrangement,sample_type,RAS_12,ALK,non-small cell lung cancer,820,69,"beta[1,4]",-6.735,0.106,2.652,-13.262,-11.771,-8.198,-6.265,-4.73,-3.337,-3.071,629.925,1.001,Metastasis,-2.54,1.96,2859,820,69,0,3748,18.404,4.75,3.45,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,ALK,non-small cell lung cancer,1652,46,"beta[2,4]",-6.722,0.111,2.643,-12.874,-11.666,-8.204,-6.285,-4.698,-3.33,-2.939,566.001,1,Primary,-2.543,1.96,4270,1652,46,0,5968,16.378,4.28,3.28,TRUE,3.21,3.71
single,Rearrangement,sample_type,RAS_12,CDKN2A,non-small cell lung cancer,1530,15,"beta[1,4]",0.481,0.016,0.526,-0.573,-0.379,0.137,0.478,0.827,1.32,1.48,1048.889,1.001,Primary,0.914,0.44,3981,1524,9,6,5520,0.601,0.36,0.01,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,FGFR3,bladder cancer,52,11,"beta[1,4]",-4.429,0.168,4.637,-14.154,-12.028,-6.272,-3.669,-1.588,0.544,0.914,760.582,1.004,Primary,-0.955,0.47,1101,52,11,0,1164,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,FGFR3,cns cancer,19,28,"beta[1,4]",-3.762,0.217,4.58,-14.165,-11.779,-5.877,-2.553,-0.643,1.357,1.847,444.742,1.015,Primary,-0.821,0.39,3475,19,28,0,3522,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,RET,non-small cell lung cancer,815,29,"beta[1,4]",-6.332,0.194,2.758,-13.17,-11.465,-7.943,-5.806,-4.217,-2.867,-2.56,203.071,1.008,Metastasis,-2.295,1.66,2909,815,29,0,3753,6.871,2.06,1.48,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,RET,non-small cell lung cancer,1663,31,"beta[2,4]",-6.337,0.195,2.81,-13.225,-11.429,-7.881,-5.788,-4.212,-2.883,-2.56,207.093,1.012,Primary,-2.255,1.62,4365,1663,31,0,6059,10.443,2.91,2.23,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,RET,thyroid cancer,7,14,"beta[1,4]",-3.951,0.111,4.02,-14.106,-11.381,-6.147,-3.112,-1.037,1.095,1.513,1302.411,1.004,Metastasis,-0.983,0.49,382,7,14,0,403,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,TMPRSS2,prostate cancer,6,276,"beta[3,4]",-0.974,0.053,1.231,-3.867,-3.204,-1.671,-0.836,-0.131,0.784,0.971,548.404,1.003,Primary,-0.791,0.37,987,5,275,1,1268,0,0,0,FALSE,2.26,2.26
single,Rearrangement,sample_type,KRAS_12,EGFR,cns cancer,19,189,"beta[1,4]",-5.33,0.14,4.851,-16.11,-13.297,-7.185,-4.415,-2.246,-0.315,0.174,1207.653,1,Primary,-1.099,0.57,3321,19,189,0,3529,0.28,0.22,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,NF1,breast cancer,27,15,"beta[1,4]",-3.561,0.296,4.618,-14.103,-11.609,-5.921,-2.63,-0.247,2.031,2.636,242.578,1.016,Primary,-0.771,0.36,5512,27,15,0,5554,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,FGFR2,hepatobiliary cancer,43,14,"beta[1,4]",-4.98,0.378,2.839,-12.231,-10.583,-6.529,-4.136,-3.06,-1.54,-1.084,56.291,1.037,Metastasis,-1.754,1.1,382,43,14,0,439,0.634,0.37,0.04,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,FGFR2,hepatobiliary cancer,65,44,"beta[2,4]",-5.015,0.39,2.796,-12.062,-10.5,-6.551,-4.141,-3.139,-1.669,-1.231,51.303,1.041,Primary,-1.794,1.14,788,65,44,0,897,2.57,0.96,0.53,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,ERG,prostate cancer,6,225,"beta[3,4]",-0.344,0.485,1.139,-3.096,-2.503,-1.012,0.081,0.468,0.792,1.197,5.53,1.182,Primary,-0.302,0.12,1037,5,224,1,1267,0,0,0,FALSE,2.26,2.26
single,Rearrangement,sample_type,KRAS_12,ROS1,non-small cell lung cancer,653,27,"beta[1,4]",-3.234,0.041,1.217,-5.937,-5.483,-3.935,-3.061,-2.376,-1.585,-1.357,886.377,1,Metastasis,-2.658,2.1,2326,652,26,1,3005,4.191,1.39,0.89,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,ROS1,non-small cell lung cancer,1257,36,"beta[2,4]",-3.602,0.043,1.293,-6.594,-5.969,-4.332,-3.356,-2.698,-1.921,-1.781,901.903,1,Primary,-2.786,2.27,3326,1257,36,0,4619,12.216,3.32,2.52,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,BRAF,cns cancer,19,21,"beta[2,4]",-3.669,0.098,3.704,-12.183,-10.843,-5.781,-3.156,-0.869,1.308,1.747,1419.798,1.001,Primary,-0.991,0.49,3482,19,21,0,3522,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,BRAF,melanoma,13,22,"beta[1,4]",-4.058,0.147,4.213,-13.975,-12.243,-6.192,-3.364,-0.955,1.265,1.759,822.774,1,Metastasis,-0.963,0.47,1703,13,22,0,1738,0,0,0,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,ETV6,breast cancer,15,15,"beta[1,4]",-4.224,0.493,4.858,-13.708,-11.459,-6.495,-3.576,-0.674,2.004,2.502,97.268,1.026,Primary,-0.87,0.42,3052,15,15,0,3082,0,0,0,FALSE,2.26,2.26
single,Rearrangement,sample_type,KRAS_12,ALK,non-small cell lung cancer,815,69,"beta[1,4]",-6.818,0.076,2.642,-13.049,-11.802,-8.117,-6.334,-4.93,-3.411,-3.032,1211.344,1.001,Metastasis,-2.581,2.01,2864,815,69,0,3748,18.253,4.71,3.43,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,ALK,non-small cell lung cancer,1642,46,"beta[2,4]",-6.761,0.07,2.641,-12.692,-11.719,-8.036,-6.299,-4.881,-3.36,-2.984,1437.569,1,Primary,-2.56,1.98,4280,1642,46,0,5968,16.233,4.25,3.27,TRUE,3.21,3.71
single,Rearrangement,sample_type,KRAS_12,CDKN2A,non-small cell lung cancer,1523,15,"beta[1,4]",0.521,0.014,0.553,-0.57,-0.414,0.157,0.507,0.89,1.433,1.61,1498.958,0.999,Primary,0.941,0.46,3988,1517,9,6,5520,0.62,0.37,0.04,TRUE,3.21,3.71
single,Rearrangement,sample_type,NRAS_12,RET,non-small cell lung cancer,11,31,"beta[2,4]",-2.925,0.11,3.54,-11.153,-9.589,-5.23,-2.45,-0.191,1.839,2.257,1043.142,1.001,Primary,-0.826,0.39,6017,11,31,0,6059,0,0,0,TRUE,2.86,2.86
single,Rearrangement,sample_type,NRAS_12,FGFR2,hepatobiliary cancer,7,44,"beta[2,4]",-3.834,0.142,3.159,-11.198,-9.871,-5.665,-3.278,-1.564,0.604,1.169,494.869,1,Primary,-1.214,0.65,846,7,44,0,897,0,0,0,TRUE,2.86,2.86
single,Rearrangement,sample_type,NRAS_12,ROS1,non-small cell lung cancer,7,36,"beta[2,4]",-2.534,0.265,3.366,-10.014,-8.801,-4.601,-2.33,0.094,2.123,2.487,161.788,1.02,Primary,-0.753,0.35,4576,7,36,0,4619,0,0,0,TRUE,2.86,2.86
single,Rearrangement,sample_type,NRAS_12,BRAF,melanoma,21,22,"beta[1,4]",-4.418,0.183,5.067,-15.087,-12.573,-6.447,-3.498,-1.168,1.025,1.38,766.731,1.001,Metastasis,-0.872,0.42,1695,21,22,0,1738,0,0,0,TRUE,2.86,2.86
single,Rearrangement,sample_type,NRAS_12,ALK,non-small cell lung cancer,11,46,"beta[2,4]",-3.472,0.099,3.439,-11.694,-9.655,-5.537,-3.117,-0.901,1.222,1.913,1199.706,0.998,Primary,-1.01,0.5,5911,11,46,0,5968,0,0,0,TRUE,2.86,2.86
single,Rearrangement,sample_type,NRAS_12,CDKN2A,non-small cell lung cancer,8,15,"beta[1,4]",-3.611,0.264,6.944,-15.09,-12.478,-5.967,-2.677,0.166,2.982,3.56,693.403,1.003,Primary,-0.52,0.22,5497,8,15,0,5520,0,0,0,TRUE,2.86,2.86
single,Rearrangement,sample_type,RAS_12C,RET,non-small cell lung cancer,145,29,"beta[1,4]",-4.509,0.494,3.446,-14.97,-11.602,-6.129,-3.606,-1.817,-0.908,-0.363,48.622,1.038,Metastasis,-1.309,0.72,3579,145,29,0,3753,0.36,0.26,0.19,TRUE,2.51,2.99
single,Rearrangement,sample_type,RAS_12C,RET,non-small cell lung cancer,290,31,"beta[2,4]",-4.506,0.49,3.436,-14.801,-11.685,-6.196,-3.629,-1.778,-0.85,-0.435,49.244,1.037,Primary,-1.311,0.72,5738,290,31,0,6059,0.689,0.39,0.24,TRUE,2.51,2.99
single,Rearrangement,sample_type,RAS_12C,ROS1,non-small cell lung cancer,128,27,"beta[1,4]",-1.351,0.219,1.236,-4.209,-3.635,-2.152,-1.198,-0.336,0.145,0.398,31.811,1.078,Metastasis,-1.093,0.56,2851,127,26,1,3005,0,0,0,TRUE,2.51,2.99
single,Rearrangement,sample_type,RAS_12C,ROS1,non-small cell lung cancer,229,36,"beta[2,4]",-1.556,0.238,1.293,-4.464,-3.973,-2.33,-1.435,-0.532,-0.022,0.141,29.6,1.085,Primary,-1.203,0.64,4354,229,36,0,4619,0.981,0.49,0.25,TRUE,2.51,2.99
single,Rearrangement,sample_type,RAS_12C,ALK,non-small cell lung cancer,145,69,"beta[1,4]",-5.37,0.104,2.975,-12.336,-10.696,-7.057,-4.921,-3.132,-1.566,-1.22,817.113,1.004,Metastasis,-1.805,1.15,3534,145,69,0,3748,1.868,0.77,0.26,TRUE,2.51,2.99
single,Rearrangement,sample_type,RAS_12C,ALK,non-small cell lung cancer,288,46,"beta[2,4]",-5.398,0.104,2.907,-12.169,-10.701,-7.206,-4.906,-3.211,-1.549,-1.172,780.65,1.007,Primary,-1.857,1.2,5634,288,46,0,5968,1.411,0.63,0.26,TRUE,2.51,2.99
single,Rearrangement,sample_type,RAS_12C,CDKN2A,non-small cell lung cancer,264,15,"beta[1,4]",1.412,0.02,0.677,-0.018,0.257,0.989,1.407,1.898,2.453,2.645,1112.673,1,Primary,2.086,1.43,5244,261,12,3,5520,4.665,1.51,0.67,TRUE,2.51,2.99
single,Rearrangement,sample_type,KRAS_12C,RET,non-small cell lung cancer,407,29,"beta[1,4]",-5.5,0.136,2.575,-11.557,-10.633,-6.902,-4.939,-3.732,-2.199,-1.79,359.273,1.01,Metastasis,-2.136,1.49,3317,407,29,0,3753,2.514,0.95,0.74,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_12C,RET,non-small cell lung cancer,779,31,"beta[2,4]",-5.509,0.143,2.591,-11.745,-10.752,-6.87,-4.925,-3.727,-2.137,-1.789,328.901,1.008,Primary,-2.126,1.47,5249,779,31,0,6059,3.516,1.22,0.92,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_12C,FGFR2,hepatobiliary cancer,6,14,"beta[1,4]",-4.245,0.136,3.521,-11.994,-10.678,-6.494,-3.624,-1.652,0.512,1.107,674.12,1.008,Metastasis,-1.206,0.64,419,6,14,0,439,0,0,0,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_12C,ROS1,non-small cell lung cancer,344,27,"beta[1,4]",-2.485,0.037,1.156,-5.206,-4.637,-3.131,-2.312,-1.665,-0.857,-0.58,980.494,1.001,Metastasis,-2.149,1.5,2635,343,26,1,3005,0.933,0.48,0.42,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_12C,ROS1,non-small cell lung cancer,596,36,"beta[2,4]",-2.707,0.038,1.241,-5.668,-4.967,-3.374,-2.5,-1.845,-1.019,-0.818,1080.912,1,Primary,-2.182,1.54,3987,596,36,0,4619,4.28,1.41,0.99,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_12C,ALK,non-small cell lung cancer,407,69,"beta[1,4]",-6.121,0.073,2.662,-12.268,-10.785,-7.675,-5.698,-4.168,-2.489,-2.127,1321.661,1,Metastasis,-2.299,1.67,3272,407,69,0,3748,7.458,2.2,1.3,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_12C,ALK,non-small cell lung cancer,770,46,"beta[2,4]",-6.15,0.076,2.71,-12.475,-10.85,-7.862,-5.769,-4.17,-2.469,-2.156,1266.689,1.001,Primary,-2.27,1.63,5152,770,46,0,5968,5.759,1.78,1.18,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_12C,CDKN2A,non-small cell lung cancer,713,15,"beta[1,4]",0.84,0.016,0.59,-0.393,-0.191,0.457,0.853,1.257,1.779,1.944,1404.979,1,Primary,1.423,0.81,4796,709,11,4,5520,1.451,0.64,0.52,TRUE,2.7,3.11
single,Rearrangement,sample_type,RAS_13,FGFR3,bladder cancer,16,11,"beta[1,4]",-3.855,0.13,4.61,-14.031,-11.847,-6.051,-3.102,-0.653,1.498,1.993,1261.381,0.999,Primary,-0.836,0.39,1137,16,11,0,1164,0,0,0,TRUE,2.99,3.3
single,Rearrangement,sample_type,RAS_13,RET,non-small cell lung cancer,96,29,"beta[1,4]",-4.987,0.515,3.42,-12.373,-11.758,-6.996,-4.223,-2.377,-0.577,-0.151,44.097,1.058,Metastasis,-1.458,0.84,3628,96,29,0,3753,0.082,0.11,0,TRUE,2.99,3.3
single,Rearrangement,sample_type,RAS_13,RET,non-small cell lung cancer,123,31,"beta[2,4]",-4.999,0.505,3.487,-12.366,-11.745,-7.003,-4.148,-2.38,-0.507,-0.034,47.711,1.053,Primary,-1.434,0.82,5905,123,31,0,6059,0.027,0.06,0,TRUE,2.99,3.3
single,Rearrangement,sample_type,RAS_13,FGFR2,hepatobiliary cancer,8,44,"beta[2,4]",-3.721,0.17,3.218,-11.541,-9.742,-5.53,-3.198,-1.338,0.615,0.955,359.572,1.01,Primary,-1.157,0.61,845,8,44,0,897,0,0,0,TRUE,2.99,3.3
single,Rearrangement,sample_type,RAS_13,ROS1,non-small cell lung cancer,77,27,"beta[1,4]",-4.517,0.161,2.959,-11.624,-10.205,-6.202,-4.161,-2.258,-0.342,-0.071,337.033,1.001,Metastasis,-1.527,0.9,2901,77,27,0,3005,0.055,0.09,0,TRUE,2.99,3.3
single,Rearrangement,sample_type,RAS_13,ROS1,non-small cell lung cancer,93,36,"beta[2,4]",-4.521,0.161,2.969,-11.431,-9.999,-6.171,-4.098,-2.257,-0.382,-0.058,338.829,1.001,Primary,-1.523,0.89,4490,93,36,0,4619,0.072,0.1,0,TRUE,2.99,3.3
single,Rearrangement,sample_type,RAS_13,BRAF,melanoma,42,22,"beta[1,4]",-4.809,0.123,4.602,-14.446,-12.692,-6.695,-3.832,-1.87,0.267,0.753,1393.964,0.999,Metastasis,-1.045,0.53,1674,42,22,0,1738,0.002,0.02,0,TRUE,2.99,3.3
single,Rearrangement,sample_type,RAS_13,ALK,non-small cell lung cancer,96,69,"beta[1,4]",-5.05,0.09,3.117,-12.25,-10.882,-6.811,-4.408,-2.868,-1.111,-0.703,1198.275,1.002,Metastasis,-1.62,0.98,3583,96,69,0,3748,0.95,0.48,0,TRUE,2.99,3.3
single,Rearrangement,sample_type,RAS_13,ALK,non-small cell lung cancer,122,46,"beta[2,4]",-4.992,0.085,3.05,-12.006,-10.635,-6.717,-4.431,-2.818,-1.131,-0.691,1283.211,0.999,Primary,-1.637,0.99,5800,122,46,0,5968,0.212,0.19,0,TRUE,2.99,3.3
single,Rearrangement,sample_type,RAS_13,CDKN2A,non-small cell lung cancer,112,15,"beta[1,4]",-4.359,0.125,4.418,-14.493,-11.789,-6.427,-3.638,-1.206,0.836,1.347,1249.001,1,Primary,-0.987,0.49,5393,112,15,0,5520,0,0,0,TRUE,2.99,3.3
single,Rearrangement,sample_type,KRAS_13,RET,non-small cell lung cancer,89,29,"beta[1,4]",-4.299,0.106,2.944,-11.079,-9.885,-6.16,-3.761,-2.099,-0.491,0.016,766.64,1.005,Metastasis,-1.461,0.84,3635,89,29,0,3753,0.053,0.09,0,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_13,RET,non-small cell lung cancer,116,31,"beta[2,4]",-4.261,0.109,2.925,-11.175,-9.805,-6.062,-3.773,-2.097,-0.391,0.109,719.426,1.005,Primary,-1.457,0.84,5912,116,31,0,6059,0.015,0.04,0,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_13,FGFR2,hepatobiliary cancer,6,44,"beta[2,4]",-4.005,0.164,3.424,-12.013,-10.268,-5.913,-3.654,-1.452,0.578,0.956,437.757,1.002,Primary,-1.17,0.62,847,6,44,0,897,0,0,0,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_13,ROS1,non-small cell lung cancer,70,27,"beta[1,4]",-4.517,0.104,3.075,-11.685,-10.089,-6.213,-4.038,-2.17,-0.421,0.05,869.757,1,Metastasis,-1.469,0.85,2908,70,27,0,3005,0.027,0.06,0,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_13,ROS1,non-small cell lung cancer,87,36,"beta[2,4]",-4.503,0.103,3.061,-11.728,-9.853,-6.344,-3.961,-2.168,-0.356,0.043,890.541,0.999,Primary,-1.471,0.85,4496,87,36,0,4619,0.048,0.08,0,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_13,ALK,non-small cell lung cancer,89,69,"beta[1,4]",-5.099,0.094,2.984,-11.66,-10.656,-6.889,-4.7,-2.835,-1.098,-0.671,1012.436,1.001,Metastasis,-1.709,1.06,3590,89,69,0,3748,0.825,0.44,0,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_13,ALK,non-small cell lung cancer,115,46,"beta[2,4]",-5.07,0.102,3.059,-11.907,-11.044,-6.958,-4.597,-2.738,-0.882,-0.511,898.754,1.001,Primary,-1.658,1.01,5807,115,46,0,5968,0.173,0.17,0,TRUE,2.7,3.11
single,Rearrangement,sample_type,KRAS_13,CDKN2A,non-small cell lung cancer,106,15,"beta[1,4]",-4.354,0.137,4.406,-15.156,-12.212,-6.542,-3.447,-1.204,0.827,1.185,1027.991,1.001,Primary,-0.988,0.49,5399,106,15,0,5520,0,0,0,TRUE,2.7,3.11
single,Rearrangement,sample_type,NRAS_13,BRAF,melanoma,25,22,"beta[1,4]",-4.465,0.158,5.028,-16.002,-12.319,-6.524,-3.548,-1.164,0.961,1.243,1008.275,1.002,Metastasis,-0.888,0.43,1691,25,22,0,1738,0,0,0,TRUE,1.3,1.3
single,Rearrangement,sample_type,RAS_61,FGFR3,bladder cancer,32,11,"beta[1,4]",-4.336,0.134,4.665,-15.078,-11.971,-6.5,-3.496,-1.152,0.785,1.357,1212.619,1.003,Primary,-0.93,0.45,1121,32,11,0,1164,0,0,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,FGFR3,cns cancer,24,28,"beta[1,4]",-4.01,0.138,4.634,-14.725,-11.901,-6.31,-3.041,-0.828,1.317,1.724,1128.767,1.005,Primary,-0.865,0.41,3470,24,28,0,3522,0,0,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,RET,non-small cell lung cancer,95,29,"beta[1,4]",-4.453,0.103,3.068,-11.909,-10.412,-6.065,-3.859,-2.291,-0.549,-0.153,883.604,1.005,Metastasis,-1.451,0.83,3629,95,29,0,3753,0.077,0.11,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,RET,non-small cell lung cancer,143,31,"beta[2,4]",-4.439,0.11,3.07,-12.032,-10.517,-6.114,-3.924,-2.234,-0.476,-0.071,777.774,1.005,Primary,-1.446,0.83,5885,143,31,0,6059,0.075,0.11,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,RET,thyroid cancer,54,14,"beta[1,4]",-5.525,0.114,3.958,-14.796,-12.434,-7.537,-4.608,-2.703,-1.003,-0.579,1201.581,1,Metastasis,-1.396,0.79,335,54,14,0,403,1.207,0.57,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,TMPRSS2,prostate cancer,10,190,"beta[1,4]",-1.277,0.029,0.869,-3.321,-2.901,-1.775,-1.225,-0.673,0.024,0.192,892.161,1.001,Metastasis,-1.47,0.85,549,9,189,1,748,0.579,0.35,0,FALSE,1.9,2.51
single,Rearrangement,sample_type,RAS_61,TMPRSS2,prostate cancer,10,276,"beta[3,4]",-1.267,0.031,0.875,-3.248,-2.872,-1.767,-1.206,-0.67,0.016,0.225,805.641,1.002,Primary,-1.447,0.83,983,9,275,1,1268,0.271,0.22,0,FALSE,1.9,2.51
single,Rearrangement,sample_type,RAS_61,EGFR,cns cancer,24,189,"beta[1,4]",-5.58,0.143,4.837,-17.33,-13.795,-7.487,-4.512,-2.457,-0.608,-0.181,1146.267,0.999,Primary,-1.154,0.6,3316,24,189,0,3529,0.51,0.32,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,FGFR2,hepatobiliary cancer,12,14,"beta[1,4]",-4.502,0.183,3.068,-12.058,-10.56,-6.189,-3.834,-2.317,-0.565,-0.161,280.13,1.014,Metastasis,-1.467,0.85,413,12,14,0,439,0,0,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,FGFR2,hepatobiliary cancer,23,44,"beta[2,4]",-4.531,0.192,3.06,-12.067,-10.52,-6.072,-3.893,-2.38,-0.668,-0.28,253.358,1.015,Primary,-1.481,0.86,830,23,44,0,897,0.378,0.27,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,ERG,prostate cancer,10,161,"beta[1,4]",-1.893,0.038,1.193,-4.604,-4.172,-2.622,-1.715,-1.036,-0.218,0.007,972.818,1.003,Metastasis,-1.586,0.95,582,9,160,1,752,0.247,0.21,0,FALSE,1.9,2.51
single,Rearrangement,sample_type,RAS_61,ERG,prostate cancer,10,225,"beta[3,4]",-2.128,0.042,1.263,-5.053,-4.533,-2.836,-1.953,-1.2,-0.426,-0.2,898.888,1.002,Primary,-1.685,1.04,1032,10,225,0,1267,1.123,0.54,0,FALSE,1.9,2.51
single,Rearrangement,sample_type,RAS_61,ROS1,non-small cell lung cancer,70,27,"beta[1,4]",-4.172,0.252,3.049,-10.917,-9.884,-6.254,-3.652,-1.768,-0.197,0.07,146.408,1.038,Metastasis,-1.368,0.77,2908,70,27,0,3005,0.027,0.06,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,ROS1,non-small cell lung cancer,99,36,"beta[2,4]",-4.168,0.241,3.013,-10.881,-9.757,-6.224,-3.643,-1.806,-0.27,-0.079,156.61,1.036,Primary,-1.384,0.78,4484,99,36,0,4619,0.098,0.12,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,BRAF,cns cancer,24,21,"beta[2,4]",-3.937,0.097,3.696,-12.744,-10.827,-6.083,-3.259,-1.296,0.98,1.535,1460.793,0.999,Primary,-1.065,0.54,3477,24,21,0,3522,0,0,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,BRAF,melanoma,386,22,"beta[1,4]",-6.393,0.136,4.558,-15.508,-13.074,-8.151,-5.484,-3.533,-1.847,-1.53,1122.167,0.999,Metastasis,-1.403,0.79,1330,386,22,0,1738,5.126,1.63,0.33,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,BRAF,prostate cancer,10,11,"beta[1,4]",-3.762,0.122,4.376,-13.652,-11.609,-5.959,-2.918,-0.863,1.687,2.287,1296.561,1.002,Metastasis,-0.86,0.41,881,10,11,0,902,0,0,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,ALK,non-small cell lung cancer,95,69,"beta[1,4]",-4.989,0.095,3.013,-12.338,-10.631,-6.745,-4.38,-2.793,-1.145,-0.78,1009.038,1.001,Metastasis,-1.656,1.01,3584,95,69,0,3748,0.932,0.48,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,ALK,non-small cell lung cancer,141,46,"beta[2,4]",-4.987,0.099,2.987,-11.712,-10.275,-6.802,-4.614,-2.698,-0.956,-0.45,911.338,1.001,Primary,-1.67,1.02,5781,141,46,0,5968,0.327,0.25,0,TRUE,3.11,3.71
single,Rearrangement,sample_type,RAS_61,CDKN2A,non-small cell lung cancer,132,15,"beta[1,4]",1.607,0.022,0.837,-0.198,0.173,1.125,1.674,2.153,2.911,3.057,1386.683,1,Primary,1.92,1.26,5375,130,13,2,5520,3.731,1.27,0.27,TRUE,3.11,3.71
single,Rearrangement,sample_type,KRAS_61,FGFR3,cns cancer,9,28,"beta[1,4]",-3.883,0.328,4.743,-14.642,-11.855,-6.843,-3.012,-0.276,2.135,2.617,209.316,1.014,Primary,-0.819,0.38,3485,9,28,0,3522,0,0,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,RET,non-small cell lung cancer,70,29,"beta[1,4]",-4.55,0.267,2.88,-10.751,-9.619,-6.483,-4.241,-2.407,-0.319,0.185,116.039,1.03,Metastasis,-1.58,0.94,3654,70,29,0,3753,0.003,0.02,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,RET,non-small cell lung cancer,104,31,"beta[2,4]",-4.523,0.279,2.887,-10.832,-9.627,-6.666,-4.281,-2.35,-0.337,0.132,106.751,1.032,Primary,-1.567,0.93,5924,104,31,0,6059,0.002,0.02,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,EGFR,cns cancer,9,189,"beta[1,4]",-4.564,0.4,5.059,-15.906,-12.761,-6.566,-3.214,-1.386,0.2,0.758,160.308,1.015,Primary,-0.902,0.44,3331,9,189,0,3529,0,0,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,FGFR2,hepatobiliary cancer,7,14,"beta[1,4]",-4.246,0.098,3.09,-11.427,-9.685,-6.217,-3.742,-1.93,0.047,0.485,1004.322,1.002,Metastasis,-1.374,0.77,418,7,14,0,439,0,0,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,FGFR2,hepatobiliary cancer,11,44,"beta[2,4]",-4.265,0.1,3.052,-11.309,-9.743,-6.189,-3.721,-1.981,-0.163,0.256,922.877,1.003,Primary,-1.398,0.79,842,11,44,0,897,0.003,0.02,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,ROS1,non-small cell lung cancer,48,27,"beta[1,4]",-4.186,0.163,3.07,-11.84,-10.129,-5.903,-3.419,-2.096,-0.258,0.141,353.683,1.014,Metastasis,-1.363,0.76,2930,48,27,0,3005,0,0,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,ROS1,non-small cell lung cancer,71,36,"beta[2,4]",-4.149,0.155,3.045,-11.57,-10.042,-5.814,-3.43,-2.089,-0.225,0.34,386.462,1.015,Primary,-1.363,0.76,4512,71,36,0,4619,0.005,0.03,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,BRAF,cns cancer,9,21,"beta[2,4]",-3.572,0.097,3.9,-12.817,-11.017,-5.967,-2.948,-0.678,1.749,2.447,1617.549,0.999,Primary,-0.916,0.44,3492,9,21,0,3522,0,0,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,ALK,non-small cell lung cancer,70,69,"beta[1,4]",-4.795,0.102,3.01,-11.877,-10.36,-6.533,-4.361,-2.506,-0.854,-0.364,878.132,0.999,Metastasis,-1.593,0.95,3609,70,69,0,3748,0.501,0.32,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,ALK,non-small cell lung cancer,104,46,"beta[2,4]",-4.807,0.106,3.092,-12.198,-10.792,-6.536,-4.359,-2.484,-0.691,-0.281,846.22,1,Primary,-1.555,0.92,5818,104,46,0,5968,0.116,0.13,0,TRUE,3.11,3.46
single,Rearrangement,sample_type,KRAS_61,CDKN2A,non-small cell lung cancer,97,15,"beta[1,4]",1.849,0.025,0.846,-0.019,0.331,1.351,1.896,2.442,3.113,3.258,1132.994,1,Primary,2.187,1.54,5410,95,13,2,5520,5.919,1.82,0.75,TRUE,3.11,3.46
single,Rearrangement,sample_type,HRAS_61,FGFR3,bladder cancer,23,11,"beta[1,4]",-4.296,0.225,4.586,-14.151,-11.252,-6.655,-3.404,-1.09,1.172,1.661,414.167,1.005,Primary,-0.937,0.46,1130,23,11,0,1164,0,0,0,TRUE,2.26,2.51
single,Rearrangement,sample_type,HRAS_61,RET,thyroid cancer,10,14,"beta[1,4]",-4.263,0.128,4.526,-14.166,-12.066,-6.204,-3.351,-1.258,0.651,1.082,1244.057,1.005,Metastasis,-0.942,0.46,379,10,14,0,403,0,0,0,TRUE,2.26,2.51
single,Rearrangement,sample_type,HRAS_61,TMPRSS2,prostate cancer,7,190,"beta[1,4]",-1.948,0.037,1.344,-5.106,-4.22,-2.6,-1.798,-1.026,-0.082,0.124,1338.763,1.001,Metastasis,-1.449,0.83,551,7,190,0,748,1.243,0.58,0,FALSE,1.9,2.51
single,Rearrangement,sample_type,HRAS_61,TMPRSS2,prostate cancer,6,276,"beta[3,4]",-1.695,0.034,1.242,-4.438,-3.906,-2.372,-1.619,-0.809,0.103,0.387,1350.113,1,Primary,-1.364,0.76,987,5,275,1,1268,0,0,0,FALSE,1.9,2.51
single,Rearrangement,sample_type,HRAS_61,ERG,prostate cancer,7,161,"beta[1,4]",-5.329,0.101,3.115,-13.064,-11.373,-7.021,-4.848,-2.905,-1.271,-0.84,953.346,1.002,Metastasis,-1.711,1.06,584,7,161,0,752,0.855,0.45,0,FALSE,1.9,2.51
single,Rearrangement,sample_type,HRAS_61,ERG,prostate cancer,6,225,"beta[3,4]",-5.344,0.101,3.105,-13.001,-11.374,-7.017,-4.827,-3.001,-1.209,-0.805,941.094,1.002,Primary,-1.721,1.07,1036,6,225,0,1267,0.367,0.26,0,FALSE,1.9,2.51
single,Rearrangement,sample_type,HRAS_61,BRAF,melanoma,7,22,"beta[1,4]",-3.891,0.139,5.125,-14.344,-12.22,-6.177,-2.948,-0.561,1.9,2.431,1360.562,0.999,Metastasis,-0.759,0.35,1709,7,22,0,1738,0,0,0,TRUE,2.26,2.51
single,Rearrangement,sample_type,HRAS_61,BRAF,prostate cancer,7,11,"beta[1,4]",-3.859,0.148,4.842,-15.749,-12.538,-6.112,-3.033,-0.447,1.978,2.35,1068.482,1.002,Metastasis,-0.797,0.37,884,7,11,0,902,0,0,0,TRUE,2.26,2.51
single,Rearrangement,sample_type,NRAS_61,FGFR3,cns cancer,14,28,"beta[1,4]",-3.804,0.161,4.644,-13.972,-11.895,-6.085,-3.004,-0.571,1.88,2.366,835.444,1.005,Primary,-0.819,0.38,3480,14,28,0,3522,0,0,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,RET,non-small cell lung cancer,21,29,"beta[1,4]",-3.566,0.155,3.392,-11.234,-9.784,-5.582,-3.254,-0.989,1.184,1.643,477.351,1.002,Metastasis,-1.051,0.53,3703,21,29,0,3753,0,0,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,RET,non-small cell lung cancer,36,31,"beta[2,4]",-3.58,0.162,3.446,-11.526,-10.081,-5.516,-3.164,-1.005,1.207,1.677,453.968,1.003,Primary,-1.039,0.52,5992,36,31,0,6059,0,0,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,RET,thyroid cancer,41,14,"beta[1,4]",-5.211,0.181,4.047,-14.632,-12.408,-7.147,-4.348,-2.563,-0.582,-0.083,497.739,1.008,Metastasis,-1.288,0.7,348,41,14,0,403,0.692,0.39,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,EGFR,cns cancer,14,189,"beta[1,4]",-5.086,0.117,4.348,-15.176,-12.901,-7.097,-4.173,-2.216,-0.076,0.434,1376.945,1,Primary,-1.17,0.62,3326,14,189,0,3529,0.088,0.12,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,FGFR2,hepatobiliary cancer,11,44,"beta[2,4]",-4.189,0.18,3.229,-11.704,-10.081,-6.164,-3.628,-1.787,0.101,0.467,323.052,1.005,Primary,-1.297,0.71,842,11,44,0,897,0.003,0.02,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,ROS1,non-small cell lung cancer,19,27,"beta[1,4]",-4.184,0.43,3.252,-11.499,-9.125,-6.753,-3.853,-1.654,0.548,0.935,57.089,1.056,Metastasis,-1.286,0.7,2959,19,27,0,3005,0,0,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,ROS1,non-small cell lung cancer,27,36,"beta[2,4]",-4.232,0.423,3.293,-11.636,-9.452,-6.948,-3.85,-1.616,0.489,1.05,60.714,1.055,Primary,-1.285,0.7,4556,27,36,0,4619,0,0,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,BRAF,cns cancer,14,21,"beta[2,4]",-3.702,0.104,3.746,-11.954,-10.276,-5.967,-3.121,-0.95,1.348,1.848,1290.094,1.001,Primary,-0.988,0.49,3487,14,21,0,3522,0,0,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,BRAF,melanoma,376,22,"beta[1,4]",-6.446,0.18,3.794,-15.109,-12.475,-8.327,-5.777,-3.781,-1.994,-1.698,443.987,1.005,Metastasis,-1.699,1.05,1340,376,22,0,1738,4.927,1.58,0.46,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,ALK,non-small cell lung cancer,21,69,"beta[1,4]",-4.006,0.107,3.234,-11.856,-10.274,-5.881,-3.374,-1.607,0.101,0.551,917.547,1.004,Metastasis,-1.239,0.67,3658,21,69,0,3748,0,0,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,ALK,non-small cell lung cancer,35,46,"beta[2,4]",-3.95,0.105,3.218,-11.841,-10.038,-5.849,-3.347,-1.6,0.225,0.738,933.307,1.004,Primary,-1.227,0.66,5887,35,46,0,5968,0,0,0,TRUE,3.11,3.53
single,Rearrangement,sample_type,NRAS_61,CDKN2A,non-small cell lung cancer,33,15,"beta[1,4]",-3.78,0.132,4.42,-14.411,-11.505,-6.236,-3.041,-0.602,1.813,2.362,1116.182,1.002,Primary,-0.855,0.41,5472,33,15,0,5520,0,0,0,TRUE,3.11,3.53
